ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR Convergence 2024

Abstract Number: 2073

Ultrasound Findings of Activity in Patients with Inflammatory Myopathies and Clinical and Laboratory Comparison

Carina Soto-Fajardo1, Alejandra Espinosa-Orantes2, Alejandra Enríquez-Luna3, Fabian Carranza Enriquez4, Tabata Cano-Gamez3, Ana Mora-Rosas5, Rosa Elena Cervantes-Ramirez5, Karen Contreras-Castillo5, Jiram Torres Ruiz6, Diana Gómez-Martin7 and Carlos Pineda8, 1Instituto Nacional de Rehabilitacion "Luis Guillermo Ibarra Ibarra", Mexico City, Mexico, 2Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Ciudad de México, Mexico, 3Instituto Nacional de Rehabilitacion, Mexico, Distrito Federal, Mexico, 4Instituto Nacional de Rehabilitación \"Luis Guillermo Ibarra Ibarra\", Ciudad de México, Mexico, 5Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Mexico, Distrito Federal, Mexico, 6INCMNSZ, Mexico, Federal District, Mexico, 7INCMNSZ, Mexico, Distrito Federal, Mexico, 8Instituto Nacional de Rehabilitacion, Mexico City, Distrito Federal, Mexico

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR Convergence 2024

Keywords: Measurement Instrument, Musculoskeletal Examination, Myopathies, Myositis, Ultrasound

Session Information

Date: Monday, November 18, 2024

Title: Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Muscle ultrasound (MUS) is a non-invasive tool that may explore the extent of muscle abnormalities and contribute to early diagnosis and follow-up of patients with Idiopathic inflammatory myopathies (IIM). This study aims to compare the ultrasonographic findings with the clinical features of disease activity of patients with IIM.

Methods: Cross-sectional study that included patients older than 18 with IIM according to the 2017 ACR/EULAR classification criteria. We evaluated the patients according to the core set measures of the International Myositis Assessment and Clinical Studies (IMACS) group. According to the clinical and laboratory evaluation (muscle weakness, decrease in MMT8 score, and elevation of creatine kinase), the patients were divided into active and inactive patients. The MUS was performed using a GE LOGIQTMe machine with a 4-12 MHz linear probe. Ten muscles were evaluated bilaterally: sternocleidomastoid, deltoid, biceps brachii, extensor carpi radialis longus, quadriceps femoris, tibialis anterior, gastrocnemius, gluteus minimus, medius, and maximus. The Siena Myositis Ultrasound Grading Scale (SMUGS) was used to evaluate muscle edema, echo-intensity changes, muscle atrophy, and power Doppler signal (PD). The sonographer was blinded to clinical and laboratory data. Descriptive analyses were performed, and we determined the sensitivity and specificity of MUS to diagnose muscle disease activity; a p-value of ≤0.05 was considered statistically significant.

Results: Eighty-seven patients were recruited. Most patients were women (71.3%). The median (interquartile range, IQR) age was 49 (33-57). The most frequent diagnosis was dermatomyositis, presented in 67 patients (77%), followed by anti-synthetase syndrome in 12 patients (13.8%), polymyositis in 2 (2.3%), and overlap myositis in 6 (6.9%). Forty-five patients (51.7%) had active myositis. Muscle edema in sternocleidomastoid, gastrocnemius, biceps brachii, and extensor carpi radialis longus were associated with muscle activity (p< 0.05). The presence of edema  defined by MUS as hypoechoic areas with septa diffusely less evident in 3 individual muscle groups to identify disease activity has a sensitivity of 87% and specificity of 80%, with an area under the curve of 0.83 (0.74-0.92).

Conclusion: The MUS, as demonstrated, allows the identification of patients with clinically active disease. This makes it a potential screening tool for suspected activity in patients with IIM, aiding in their timely and effective management.

Supporting image 1

Figure 1. Ultrasound of the deltoid muscle. A. grade 2 edema and grade 2 PD signal, grade 2 atrophy. B edema, grade 0 PD signal and atrophy.


Disclosures: C. Soto-Fajardo: None; A. Espinosa-Orantes: None; A. Enríquez-Luna: None; F. Carranza Enriquez: None; T. Cano-Gamez: None; A. Mora-Rosas: None; R. Cervantes-Ramirez: None; K. Contreras-Castillo: None; J. Torres Ruiz: None; D. Gómez-Martin: None; C. Pineda: None.

To cite this abstract in AMA style:

Soto-Fajardo C, Espinosa-Orantes A, Enríquez-Luna A, Carranza Enriquez F, Cano-Gamez T, Mora-Rosas A, Cervantes-Ramirez R, Contreras-Castillo K, Torres Ruiz J, Gómez-Martin D, Pineda C. Ultrasound Findings of Activity in Patients with Inflammatory Myopathies and Clinical and Laboratory Comparison [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/ultrasound-findings-of-activity-in-patients-with-inflammatory-myopathies-and-clinical-and-laboratory-comparison/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ultrasound-findings-of-activity-in-patients-with-inflammatory-myopathies-and-clinical-and-laboratory-comparison/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology